Tianfeng Wang

1.6k total citations
68 papers, 1.0k citations indexed

About

Tianfeng Wang is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, Tianfeng Wang has authored 68 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Cancer Research, 22 papers in Oncology and 21 papers in Molecular Biology. Recurrent topics in Tianfeng Wang's work include Breast Cancer Treatment Studies (31 papers), BRCA gene mutations in cancer (18 papers) and Breast Lesions and Carcinomas (18 papers). Tianfeng Wang is often cited by papers focused on Breast Cancer Treatment Studies (31 papers), BRCA gene mutations in cancer (18 papers) and Breast Lesions and Carcinomas (18 papers). Tianfeng Wang collaborates with scholars based in China, Ethiopia and United States. Tianfeng Wang's co-authors include Yuntao Xie, Zhaoqing Fan, Tie Fan, Benyao Lin, Tao Ouyang, Jinfeng Li, Jinfeng Li, Lu Yao, Tao Ouyang and Jianjian Wang and has published in prestigious journals such as Nucleic Acids Research, Cancer Research and Scientific Reports.

In The Last Decade

Tianfeng Wang

68 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tianfeng Wang China 18 542 487 405 305 204 68 1.0k
Thomas P. Slavin United States 16 404 0.7× 387 0.8× 262 0.6× 255 0.8× 160 0.8× 44 917
Michela Visani Italy 20 536 1.0× 540 1.1× 104 0.3× 339 1.1× 150 0.7× 56 1.3k
Goro Yoshimura Japan 17 274 0.5× 395 0.8× 202 0.5× 251 0.8× 165 0.8× 55 837
Dominiek Smeets Belgium 13 235 0.4× 283 0.6× 87 0.2× 308 1.0× 122 0.6× 19 719
Hein F.B.M. Sleddens Netherlands 15 231 0.4× 357 0.7× 179 0.4× 313 1.0× 189 0.9× 22 782
Michael S. McLemore United States 9 290 0.5× 405 0.8× 153 0.4× 224 0.7× 58 0.3× 14 708
Brunella Pilato Italy 18 302 0.6× 488 1.0× 180 0.4× 172 0.6× 92 0.5× 46 810
Salil Goorha United States 9 184 0.3× 573 1.2× 164 0.4× 222 0.7× 186 0.9× 15 1.6k
Evelyn Despierre Belgium 13 298 0.5× 420 0.9× 103 0.3× 156 0.5× 85 0.4× 17 914
Kristen M. Turner United States 12 476 0.9× 582 1.2× 68 0.2× 183 0.6× 84 0.4× 24 957

Countries citing papers authored by Tianfeng Wang

Since Specialization
Citations

This map shows the geographic impact of Tianfeng Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tianfeng Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tianfeng Wang more than expected).

Fields of papers citing papers by Tianfeng Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tianfeng Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tianfeng Wang. The network helps show where Tianfeng Wang may publish in the future.

Co-authorship network of co-authors of Tianfeng Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Tianfeng Wang. A scholar is included among the top collaborators of Tianfeng Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tianfeng Wang. Tianfeng Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dai, Wentao, et al.. (2025). Temporal Dynamics of APOE and TREM2 Expression in Microglial Activation of NMOSD Mouse Models. Molecular Neurobiology. 62(10). 13587–13600. 1 indexed citations
2.
Wang, Xinguang, Qijun Zheng, Yingjian He, et al.. (2024). Diagnostic accuracy of sentinel lymph node biopsy and wire localized clipped node biopsy after neoadjuvant chemotherapy in node-positive breast cancer. Surgery Today. 55(2). 172–179. 1 indexed citations
3.
Wang, Tianfeng, Lei Zhang, Tianjun Yang, et al.. (2023). Identification of immune-related lncRNA in sepsis by construction of ceRNA network and integrating bioinformatic analysis. BMC Genomics. 24(1). 484–484. 8 indexed citations
4.
Wang, Xiaolong, Huixue Zhang, Jianjian Wang, et al.. (2022). Dissecting and analyzing the Subclonal Mutations Associated with Poor Prognosis in Diffuse Glioma. BioMed Research International. 2022(1). 4919111–4919111. 6 indexed citations
5.
Li, Danyang, Fei Quan, Tianfeng Wang, et al.. (2022). Identification of circulating immune landscape in ischemic stroke based on bioinformatics methods. Frontiers in Genetics. 13. 921582–921582. 5 indexed citations
6.
Su, Liming, Tao Ouyang, Jinfeng Li, et al.. (2021). Single-Cell RNA Sequencing Reveals the Cellular Origin and Evolution of Breast Cancer in BRCA1 Mutation Carriers. Cancer Research. 81(10). 2600–2611. 48 indexed citations
7.
Xu, Ye, Lu Yao, Tao Ouyang, et al.. (2019). Prevalence and clinical impact of TP53 germline mutations in Chinese women with breast cancer. International Journal of Cancer. 146(2). 487–495. 17 indexed citations
8.
Chen, Xinyi, Tao Ouyang, Jinfeng Li, et al.. (2019). Co-mutation of TP53 and PIK3CA in residual disease after neoadjuvant chemotherapy is associated with poor survival in breast cancer. Journal of Cancer Research and Clinical Oncology. 145(5). 1235–1242. 14 indexed citations
9.
Ouyang, Tao, Jinfeng Li, Tianfeng Wang, et al.. (2019). Prevalence and characterization of ATM germline mutations in Chinese BRCA1/2-negative breast cancer patients. Breast Cancer Research and Treatment. 174(3). 639–647. 17 indexed citations
10.
Cao, Wei, Yingjian He, Jinfeng Li, et al.. (2018). Impact of adjuvant chemotherapy on the survival of patients with estrogen receptor≥50%, human epidermal growth factor receptor-2 negative, lymph node negative breast cancer. Zhonghua putong waike zazhi. 33(3). 223–227. 1 indexed citations
11.
Sun, Jie, Hua Meng, Lu Yao, et al.. (2017). Germline Mutations in Cancer Susceptibility Genes in a Large Series of Unselected Breast Cancer Patients. Clinical Cancer Research. 23(20). 6113–6119. 145 indexed citations
12.
Cao, Yuze, Xiaoyan Lu, Jianjian Wang, et al.. (2017). Construction of an miRNA-regulated drug-pathway network reveals drug repurposing candidates for myasthenia gravis. International Journal of Molecular Medicine. 39(2). 268–278. 16 indexed citations
13.
Wang, Jianjian, Yuze Cao, Huixue Zhang, et al.. (2016). NSDNA: a manually curated database of experimentally supported ncRNAs associated with nervous system diseases. Nucleic Acids Research. 45(D1). D902–D907. 35 indexed citations
14.
Zhang, Juan, Tao Ouyang, Jinfeng Li, et al.. (2016). Incidence of BRCA1 somatic mutations and response to neoadjuvant chemotherapy in Chinese women with triple-negative breast cancer. Gene. 584(1). 26–30. 11 indexed citations
15.
Wang, Xinguang, Ling Huo, Yingjian He, et al.. (2016). Early prediction of pathological outcomes to neoadjuvant chemotherapy in breast cancer patients using automated breast ultrasound. Chinese Journal of Cancer Research. 28(5). 478–485. 26 indexed citations
16.
Fan, Zhaoqing, Jinfeng Li, Tianfeng Wang, et al.. (2013). Level III axillary lymph nodes involvement in node positive breast cancer received neoadjuvant chemotherapy. The Breast. 22(6). 1161–1165. 10 indexed citations
17.
Liu, Yin, Ji Liao, Ye Xu, et al.. (2011). A recurrent CHEK2 p.H371Y mutation is associated with breast cancer risk in Chinese women. Human Mutation. 32(9). 1000–1003. 22 indexed citations
18.
Li, Zhaosheng, Lu Yao, Yiqiang Liu, et al.. (2011). Breast cancer subtypes and survival in Chinese women with operable primary breast cancer. Chinese Journal of Cancer Research. 23(2). 134–139. 13 indexed citations
19.
Chen, Weiqiu, Kai‐Feng Pan, Tao Ouyang, et al.. (2008). BRCA1 germline mutations and tumor characteristics in Chinese women with familial or early-onset breast cancer. Breast Cancer Research and Treatment. 117(1). 55–60. 32 indexed citations
20.
Li, Jinfeng, et al.. (2004). Preoperative chemotherapy of continuous infusion of 5-fluorouracil, epirubicin or pirarubicin and cyclophosphamine in operable primary breast cancer. Chinese Journal of Cancer Research. 16(3). 197–202. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas P. Slavin Breakdown of academic impact, for papers by Michela Visani Breakdown of academic impact, for papers by Goro Yoshimura Breakdown of academic impact, for papers by Dominiek Smeets Breakdown of academic impact, for papers by Hein F.B.M. Sleddens Breakdown of academic impact, for papers by Michael S. McLemore Breakdown of academic impact, for papers by Brunella Pilato Breakdown of academic impact, for papers by Salil Goorha Breakdown of academic impact, for papers by Evelyn Despierre Breakdown of academic impact, for papers by Kristen M. Turner
Rankless by CCL
2026